
AstraZeneca PLC
LSE:AZN

AstraZeneca PLC?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
9 667
13 276
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does AstraZeneca PLC hold over its rivals?
What risks and challenges
does AstraZeneca PLC face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of AstraZeneca PLC.
Provide an overview of the primary business activities
of AstraZeneca PLC.
What unique competitive advantages
does AstraZeneca PLC hold over its rivals?
What risks and challenges
does AstraZeneca PLC face in the near future?
Has there been any significant insider trading activity
in AstraZeneca PLC recently?
Summarize the latest earnings call
of AstraZeneca PLC.
What significant events have occurred
in AstraZeneca PLC over the past months?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for AstraZeneca PLC.
Provide P/S
for AstraZeneca PLC.
Provide P/E
for AstraZeneca PLC.
Provide P/OCF
for AstraZeneca PLC.
Provide P/FCFE
for AstraZeneca PLC.
Provide P/B
for AstraZeneca PLC.
Provide EV/S
for AstraZeneca PLC.
Provide EV/GP
for AstraZeneca PLC.
Provide EV/EBITDA
for AstraZeneca PLC.
Provide EV/EBIT
for AstraZeneca PLC.
Provide EV/OCF
for AstraZeneca PLC.
Provide EV/FCFF
for AstraZeneca PLC.
Provide EV/IC
for AstraZeneca PLC.
Show me price targets
for AstraZeneca PLC made by professional analysts.
What are the Revenue projections
for AstraZeneca PLC?
How accurate were the past Revenue estimates
for AstraZeneca PLC?
What are the Net Income projections
for AstraZeneca PLC?
How accurate were the past Net Income estimates
for AstraZeneca PLC?
What are the EPS projections
for AstraZeneca PLC?
How accurate were the past EPS estimates
for AstraZeneca PLC?
What are the EBIT projections
for AstraZeneca PLC?
How accurate were the past EBIT estimates
for AstraZeneca PLC?
Compare the revenue forecasts
for AstraZeneca PLC with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of AstraZeneca PLC and its key competitors using the latest financial data.
Compare historical revenue growth rates
of AstraZeneca PLC against its competitors.
Analyze the profit margins
(gross, operating, and net) of AstraZeneca PLC compared to its peers.
Compare the P/E ratios
of AstraZeneca PLC against its peers.
Discuss the investment returns and shareholder value creation
comparing AstraZeneca PLC with its peers.
Analyze the financial leverage
of AstraZeneca PLC compared to its main competitors.
Show all profitability ratios
for AstraZeneca PLC.
Provide ROE
for AstraZeneca PLC.
Provide ROA
for AstraZeneca PLC.
Provide ROIC
for AstraZeneca PLC.
Provide ROCE
for AstraZeneca PLC.
Provide Gross Margin
for AstraZeneca PLC.
Provide Operating Margin
for AstraZeneca PLC.
Provide Net Margin
for AstraZeneca PLC.
Provide FCF Margin
for AstraZeneca PLC.
Show all solvency ratios
for AstraZeneca PLC.
Provide D/E Ratio
for AstraZeneca PLC.
Provide D/A Ratio
for AstraZeneca PLC.
Provide Interest Coverage Ratio
for AstraZeneca PLC.
Provide Altman Z-Score Ratio
for AstraZeneca PLC.
Provide Quick Ratio
for AstraZeneca PLC.
Provide Current Ratio
for AstraZeneca PLC.
Provide Cash Ratio
for AstraZeneca PLC.
What is the historical Revenue growth
over the last 5 years for AstraZeneca PLC?
What is the historical Net Income growth
over the last 5 years for AstraZeneca PLC?
What is the current Free Cash Flow
of AstraZeneca PLC?
Discuss the annual earnings per share (EPS)
trend over the past five years for AstraZeneca PLC.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
166.4B GBP | 4.1 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
843B USD | 18.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 578.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
374.3B USD | 4.2 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.9T DKK | 6.6 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
214.3B CHF | 3.6 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
189.9B CHF | 4.4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
213.1B USD | 3.3 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
163.5B USD | 70.5 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
137.2B USD | 2.2 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
120.7B EUR | 1.3 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
Average P/S:
63.4
4.1
|
7%
|
0.6 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
18.8
|
23%
|
0.8 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
578.3
|
9%
|
64.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
4.2
|
4%
|
1 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
6.6
|
16%
|
0.4 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
3.6
|
5%
|
0.7 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
4.4
|
3%
|
1.5 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
3.3
|
5%
|
0.7 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
70.5
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
2.2
|
-1%
|
N/A |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
1.3
|
6%
|
0.2 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.